News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
580,491 Results
Type
Article (16431)
Company Profile (159)
Press Release (563899)
Multimedia
Podcasts (77)
Webinars (11)
Section
Business (199477)
Career Advice (511)
Deals (30657)
Drug Delivery (78)
Drug Development (61561)
Employer Resources (51)
FDA (11369)
Job Trends (10975)
News (281733)
Policy (21955)
Tag
2025 Best Places to Work (1)
2026 Best Places to Work (1)
2027 BioCapital Standard (3)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (2)
2027 Genetown Premier (1)
2027 Genetown Standard (6)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (6)
40 Under 40 (1)
Academia (1143)
Accelerated approval (40)
ADA (27)
Adcomms (6)
Allergies (127)
Alliances (45004)
ALS (175)
Alzheimer's disease (1363)
Antibody-drug conjugate (ADC) (520)
Approvals (12127)
Artificial intelligence (693)
ASCO (216)
Autoimmune disease (344)
Automation (61)
Bankruptcy (303)
Belgium (17)
Best Places to Work (8906)
BIO (66)
Biologics (62)
BIOSECURE Act (8)
Biosimilars (203)
BioSpace Insights (103)
Biotechnology (102)
Bispecific (34)
Bladder cancer (171)
Brain cancer (53)
Breast cancer (696)
Cancer (5380)
Cardiovascular disease (372)
Career advice (440)
Career pathing (22)
CAR-T (271)
CDC (21)
CDMO (117)
Celiac Disease (5)
Cell therapy (785)
Cervical cancer (50)
Clinical research (55883)
Collaboration (2296)
Commercialization (45)
Company closure (1)
Compensation (1668)
Complete response letters (56)
COVID-19 (1330)
CRISPR (104)
CRO (2)
C-suite (1275)
Cystic fibrosis (114)
Data (7618)
Decentralized trials (4)
Denatured (40)
Depression (142)
Dermatology (121)
Diabetes (473)
Diagnostics (5523)
Digital health (59)
Diversity (8)
Diversity, equity & inclusion (12)
Drug discovery (352)
Drug pricing (71)
Drug shortages (11)
Duchenne muscular dystrophy (241)
Earnings (80468)
Editorial (27)
Employer branding (4)
Employer resources (55)
ESMO (303)
Events (101513)
Executive appointments (1062)
Eye disease (8)
FDA (14925)
Fibrodysplasia Ossificans Progressiva (13)
Fragile X (4)
Friedreich's ataxia (23)
Frontotemporal dementia (33)
Funding (1786)
Gene editing (211)
Generative AI (53)
Gene therapy (594)
GLP-1 (570)
Government (2009)
Grass and pollen (2)
Guidances (337)
Healthcare (13330)
Hematology (130)
HIV (81)
Huntington's disease (45)
Idiopathic pulmonary fibrosis (5)
IgA nephropathy (114)
Immunology and inflammation (254)
Immuno-oncology (118)
Indications (214)
Infectious disease (1639)
Inflammatory bowel disease (181)
Inflation Reduction Act (9)
Influenza (119)
Intellectual property (320)
Interviews (63)
IPO (14317)
IRA (15)
Job creations (2414)
Job search strategy (374)
JPM (34)
Kidney cancer (21)
Kidney disease (125)
Labor market (45)
Layoffs (207)
Leadership (22)
Legal (5890)
Licensing (76)
Liver cancer (65)
Longevity (39)
Lung cancer (768)
Lung diease (16)
Lymphoma (380)
Machine learning (57)
Management (25)
Manufacturing (1110)
Marketing (30)
MASH (178)
Medical affairs (2)
Medical device (10657)
Medtech (10898)
Mergers & acquisitions (17615)
Metabolic disorders (1130)
mRNA (179)
Multiple sclerosis (181)
Multispecific (5)
NASH (10)
Netherlands (16)
Neurodegenerative disease (395)
Neuropsychiatric disorders (81)
Neuroscience (2741)
Neurotech (3)
NextGen: Class of 2026 (4670)
Non-profit (2411)
Now hiring (13)
Obesity (437)
Opinion (98)
Ovarian cancer (219)
Pain (236)
Pancreatic cancer (282)
Parkinson's disease (309)
Partnered (35)
Patents (607)
Patient advocacy (5)
Patient recruitment (657)
Patient selection (62)
Peanut (38)
People (49807)
Peptides (20)
Pharmaceutical (34)
Pharmacy benefit managers (17)
Phase 1 (17996)
Phase 2 (24928)
Phase 3 (17268)
Pipeline (10596)
Policy (113)
Postmarket research (1711)
Preclinical (7534)
Press Release (51)
Prostate cancer (264)
Psychedelics (23)
Radioligand (2)
Radiopharmaceuticals (316)
Rare diseases (940)
Real estate (4223)
Recruiting (24)
Regenerative medicine (19)
Regulatory (18671)
Reports (30)
Research institute (1212)
Resumes & cover letters (84)
Rett syndrome (56)
RNA editing (26)
RSV (67)
Schizophrenia (152)
Series A (353)
Series B (241)
Service/supplier (5)
Sickle cell disease (90)
Special edition (10)
Spinal muscular atrophy (116)
Sponsored (27)
Startups (3169)
Stem cells (2)
Stomach cancer (8)
Substance use disorders (17)
Supply chain (106)
Switzerland (6)
Tariffs (36)
The Weekly (35)
Vaccines (693)
Venture capital (110)
Weight loss (218)
Wet AMD (4)
Women's health (135)
Worklife (2)
Date
Last 7 days (618)
Last 30 days (2159)
Last 365 days (24449)
2026 (20503)
2025 (23966)
2024 (28014)
2023 (32114)
2022 (40968)
2021 (44573)
2020 (41692)
2019 (32813)
2018 (24402)
2017 (23609)
2016 (22482)
2015 (28839)
2014 (24729)
2013 (20664)
2012 (22600)
2011 (22978)
2010 (22218)
Location
Africa (382)
Alabama (105)
Alaska (6)
Arizona (365)
Arkansas (13)
Asia (27109)
Australia (3806)
California (14309)
Canada (3778)
China (1088)
Colorado (597)
Connecticut (537)
Delaware (355)
Europe (52215)
Florida (2140)
Georgia (470)
Hawaii (4)
Idaho (59)
Illinois (1023)
India (104)
Indiana (429)
Iowa (27)
Japan (658)
Kansas (123)
Kentucky (55)
Louisiana (37)
Maine (89)
Maryland (1464)
Massachusetts (9723)
Michigan (348)
Minnesota (709)
Mississippi (7)
Missouri (119)
Montana (22)
Nebraska (11)
Nevada (145)
New Hampshire (77)
New Jersey (3412)
New Mexico (23)
New York (3484)
North Carolina (1737)
North Dakota (12)
Northern California (7314)
Ohio (390)
Oklahoma (23)
Oregon (28)
Pennsylvania (2710)
Puerto Rico (30)
Rhode Island (47)
South America (582)
South Carolina (94)
South Dakota (2)
Southern California (5864)
Tennessee (208)
Texas (2440)
United States (48241)
Utah (444)
Vermont (2)
Virginia (254)
Washington D.C. (50)
Washington State (1163)
West Virginia (4)
Wisconsin (128)
Wyoming (3)
580,491 Results for "llr partners inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TruTechnologies Secures Significant Growth Investment From LLR Partners
May 28, 2025
·
3 min read
Earnings
BMS drops Prothena-partnered neuro drug, sales outlook improves on a Q3 beat
In addition to canning an Orum-acquired blood cancer candidate last month, Bristol Myers Squibb cut a Prothena-partnered neuro asset in the third quarter. But with sales climbing 7%, the Big Pharma raised its full-year revenue forecast.
October 29, 2026
·
4 min read
·
Gabrielle Masson
antibody-drug conjugate (ADC)
ESMO 2026: Merck’s Kelun-partnered ADC hits the ‘Goldilocks zone,’ VP says
At the European Society for Medical Oncology meeting this weekend, Merck will showcase three late-stage trials of its Kelun-Biotech–partnered TROP2-directed antibody sac-TMT that VP of Chemistry Alan Northrup says gets the payload release “just right.”
October 22, 2026
·
5 min read
·
Heather McKenzie
Cancer
Moderna stock nearly doubles as Merck-partnered mRNA cancer vaccine meets Phase 3 goal
Melanoma was slower to recur in patients receiving Merck and Moderna’s mRNA vaccine with Keytruda, supporting use of the combination in adjuvant treatment. The partners plan to take the data to the FDA.
August 19, 2026
·
3 min read
·
Nick Paul Taylor
Approvals
Partner’s Bizengri cleared by FDA for ultra-rare cancer days after winning priority voucher
Partner Therapeutics announced last week that the FDA had granted Bizengri a Commissioner’s National Priority Voucher to accelerate drug review.
May 11, 2026
·
2 min read
·
Tristan Manalac
Press Releases
INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro ™
October 14, 2026
·
1 min read
Press Releases
Immuno-Oncology Pioneer Dr. Michael Kalos Joins Kos Biotechnology Partners as Venture Partner
September 10, 2026
·
3 min read
Press Releases
Surgery Partners, Inc. Announces Second Quarter 2026 Results Reaffirms Full Year 2026 Guidance
August 10, 2026
·
19 min read
Artificial intelligence
Secretive AI drug hunter Xaira dips toe into dealmaking with hunt for partners
A mostly black box since emerging with more than a billion dollars in hand, Xaira Therapeutics is slowly pulling back the curtain, revealing plans to find partners and validate its pipeline.
July 8, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2Q26
August 12, 2026
·
2 min read
1 of 58,050
Next